BI
BIIB
Market ClosedBiogen Inc.
US
7.50K employees
CEO: Christopher A. Viehbacher
Founded: 1991
$253.40
+$0.00(+NaN%)
Market Cap
37.46B
Beta
0.17
52W Range
N/A
Dividend Yield
0.00%
Comprehensive Valuation
In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: Biogen’s current price shows a 32.9% implied upside against a high-confidence fair value of $336.69, suggesting undervaluation. Monte Carlo analysis indicates substantial volatility (CV 196.33%) with 22.2% downside risk below current price, reflecting high uncertainty despite attractive median and base case valuations. Financial health reveals strong liquidity but weak growth and profitability, adding nuance to risk assessment.
Enhanced Football Field Analysis
Loading comprehensive valuation data...
Fetching multi-methodology valuation ranges...
Explore BIIB
BIIB in the Healthcare
Large Cap